StockNews.com upgraded shares of American Vanguard (NYSE:AVD – Free Report) from a sell rating to a hold rating in a report issued on Wednesday morning.
Separately, Lake Street Capital began coverage on shares of American Vanguard in a research report on Monday, July 22nd. They set a buy rating and a $14.00 price objective for the company. One equities research analyst has rated the stock with a hold rating and four have issued a buy rating to the stock. According to data from MarketBeat.com, American Vanguard currently has a consensus rating of Moderate Buy and a consensus price target of $16.67.
View Our Latest Stock Report on AVD
American Vanguard Stock Down 0.2 %
American Vanguard (NYSE:AVD – Get Free Report) last released its quarterly earnings data on Thursday, August 8th. The basic materials company reported ($0.09) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.01) by ($0.08). American Vanguard had a negative net margin of 0.60% and a positive return on equity of 1.85%. The business had revenue of $128.21 million during the quarter, compared to the consensus estimate of $134.20 million. Sell-side analysts anticipate that American Vanguard will post 0.02 earnings per share for the current year.
Insider Transactions at American Vanguard
In other news, Director Keith M. Rosenbloom purchased 33,555 shares of American Vanguard stock in a transaction that occurred on Wednesday, August 28th. The stock was acquired at an average cost of $5.66 per share, for a total transaction of $189,921.30. Following the purchase, the director now directly owns 1,047,410 shares of the company’s stock, valued at approximately $5,928,340.60. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. In other American Vanguard news, Director Keith M. Rosenbloom bought 104,492 shares of the firm’s stock in a transaction on Friday, August 30th. The shares were purchased at an average price of $5.74 per share, for a total transaction of $599,784.08. Following the transaction, the director now directly owns 1,168,682 shares in the company, valued at approximately $6,708,234.68. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Director Keith M. Rosenbloom purchased 33,555 shares of the company’s stock in a transaction dated Wednesday, August 28th. The stock was acquired at an average price of $5.66 per share, with a total value of $189,921.30. Following the completion of the transaction, the director now owns 1,047,410 shares of the company’s stock, valued at approximately $5,928,340.60. The disclosure for this purchase can be found here. Over the last quarter, insiders have bought 163,047 shares of company stock worth $938,205. Company insiders own 10.10% of the company’s stock.
Institutional Investors Weigh In On American Vanguard
Large investors have recently added to or reduced their stakes in the stock. Gladius Capital Management LP bought a new stake in shares of American Vanguard during the 2nd quarter valued at $32,000. Nisa Investment Advisors LLC grew its stake in American Vanguard by 7,554.5% during the second quarter. Nisa Investment Advisors LLC now owns 4,210 shares of the basic materials company’s stock worth $36,000 after buying an additional 4,155 shares in the last quarter. Point72 DIFC Ltd grew its stake in American Vanguard by 195.7% during the second quarter. Point72 DIFC Ltd now owns 5,080 shares of the basic materials company’s stock worth $44,000 after buying an additional 3,362 shares in the last quarter. Allspring Global Investments Holdings LLC bought a new position in American Vanguard in the 2nd quarter valued at about $118,000. Finally, EntryPoint Capital LLC raised its position in shares of American Vanguard by 363.9% in the 1st quarter. EntryPoint Capital LLC now owns 10,118 shares of the basic materials company’s stock valued at $131,000 after buying an additional 7,937 shares in the last quarter. Institutional investors and hedge funds own 79.04% of the company’s stock.
About American Vanguard
American Vanguard Corporation, through its subsidiaries, develops, manufactures, and markets specialty chemicals for agricultural, commercial, and consumer uses in the United States and internationally. It manufactures and formulates chemicals, including insecticides, fungicides, herbicides, soil health, plant nutrition, molluscicides, growth regulators, soil fumigants, and biorationals in liquid, powder, and granular forms for crops, turf and ornamental plants, and human and animal health protection.
Read More
- Five stocks we like better than American Vanguard
- ESG Stocks, What Investors Should Know
- CarMax’s Impressive Rally: What Investors Should Watch Next
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- MarketBeat Week in Review – 9/23 – 9/27
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Wake Up to This Biotech Stock That Still Has Big Potential Upside
Receive News & Ratings for American Vanguard Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Vanguard and related companies with MarketBeat.com's FREE daily email newsletter.